|

Healing Maps: From Ketamine Clinics to Psychedelic Retreats | The Yelp of Psychedelic Therapies

ByPsychedelic Spotlight



In today’s episode, Psychedelic Spotlight sits down with the founders of Healing Maps, Cory Jones and Mark Goldhar.

Healing Maps is a new company which aims to connect depression patients with Ketamine Clinics near them. Once other psychedelic therapies, such as psilocybin therapy and MDMA therapy, become legal, they will expand to those treatments also.
Healing Maps also provides information on ayahuasca and ibogaine retreats, in countries where these substances are legal.

Ultimately, Healing Maps aims to build a media organization that educates people on the potential benefits of psychedelic medicines, and ensure as many people as possible get help for their mental health conditions, be it depression, anxiety, PTSD or other conditions. Destigmatizing the topic of psychedelics is central to this mission.

HealingMaps.com has over 400 clinics on their site. People can leave reviews on specific clinics, so the wider community can learn which clinics are best.
Ultimately, Healing Maps helps connect the people who need help, to the people who provide the help.
The founders also discuss their own personal psychedelic experiences, and how psychedelics will help change society.

#healingmaps #ketamineclinics #psychedelictherapy

source

Similar Posts

  • The Top 10 Psychedelics Stocks’ Financials COMPARED ( Atai, CMPS, MNMD, NUMI, RVV, DMT, TRIP+)

    Listen, Videos

    What’s up psychedelic investors! In this episode, we’ll be comparing the top 10 psychedelic stocks’ financials.
    Will look at the 4 most important financial stats for each of the top 10 companies in the Psychedelic Medicines field, selected by market cap.

    First, we will look at the market cap, because that tells us how valuable the market judges the company to be, and it tells us how easily a company can raise capital.
    Next, we will look at cash on hand.
    Third, we will look at how much a company is spending.
    Finally, we will look at revenue where applicable
    All figures are in American dollars.

    So which stocks we’ll be comparing, you may ask? We’ll look at:
    – Atai Life Sciences ( NASDAQ: ATAI)
    – Compass Pathways (NASDAQ: CMPS)
    -MindMed (NASDAQ: MNMD), ( NEO: MMED)
    – Cybin Inc (NYSE: CYBN)
    – Numinus Wellneass (TSX: NUMI) (OTC: LKYSF)
    – Revive Therapeutics (CN: RVV) (OTC: RVVTF)
    – Small Pharma ( TSX: DMT)
    -Mydecine (OTC: MYCOF) (NEO: MYCO)
    – Red Light Holland ( CSE: TRIP) (OTC: TRUFF)

    Enjoy the episode!

    Follow us on social media! 🙌
    Instagram: @thepsychedelicinvestor
    Facebook: @thepsychedelicinvestor

    Want to collaborate? Send us an email at:
    thepsychedelicinvestor@gmail.com

    Music from:
    www.bensound.com

    Video editing: @themyaholy

    Check out our Benziga discounts
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

    #MindMed #ATAISTOCK #PsychedelicStocks

  • New Psychedelic ETF (PSYK) UPDATE: What Does This Mean For MindMed, NUMI & Compass Pathways?

    Listen, Videos

    In our previous video, we discussed the upcoming IPO of Horizons Psychedelic ETF (PSYK).
    Recently, on January 27th, PSYK began trading on the Canadian NEO Stock Exchange.
    In this episode we are going to discuss the psychedelic ETF and what it means for MindMed, NUMI, Compass Pathways and other stocks in the psychedelic sector.

    We will cover a few things such as:

    – PSYK’s fundamentals
    – PSYK’s CEO Steve Hawkins
    -Is Horizons ETF actively or passively managed?
    – What psychedelic stocks are included in the ETF?
    – How often does th ETF reorganize its stock holdings?
    – How is the size of the individual stocks’ position decided on?
    – Is it worth investing in PSYK now?
    – What will happen to MindMed (MMED/MMEDF), Numinus Wellness (NUMI), Compass Pathways (CMPS) and the other stocks once they are included?

    ***A quick reminder, the psychedelic sector is at a VERY early stage, and all of these companies, large-cap and small cap alike, will need to attract more funding to complete their clinical trials and bring their products to market. PSYK will however contribute to this sector as it will bring more funding to the industry as a whole, which will both help individual companies and the wider mission of treating mental health disorders.

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!

    Follow us on social media! 🙌
    Instagram: @psychedelicinvestor
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    #PSYK #MindMed #MMED

  • The Awakening of Consciousness Conference with Paul Karasik

    Listen, Podcasts

    In this episode, Matthew and Paul discuss The Psychedelic Institute’s aspirations with the launch of the Awakening of Consciousness Conference, the differences between legalization and decriminalization, and the importance of being brave, and thinking outside the box in understanding what it takes to make the most of one’s own experience of sacred plant medicines.